Gehad M. Subaiea

699 total citations
30 papers, 509 citations indexed

About

Gehad M. Subaiea is a scholar working on Molecular Biology, Physiology and Pharmacology. According to data from OpenAlex, Gehad M. Subaiea has authored 30 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Physiology and 5 papers in Pharmacology. Recurrent topics in Gehad M. Subaiea's work include Alzheimer's disease research and treatments (8 papers), Heavy Metal Exposure and Toxicity (5 papers) and Computational Drug Discovery Methods (3 papers). Gehad M. Subaiea is often cited by papers focused on Alzheimer's disease research and treatments (8 papers), Heavy Metal Exposure and Toxicity (5 papers) and Computational Drug Discovery Methods (3 papers). Gehad M. Subaiea collaborates with scholars based in Saudi Arabia, United States and Egypt. Gehad M. Subaiea's co-authors include Nasser H. Zawia, Lina Adwan, Syed Waseem Bihaqi, Thamir M. Alshammari, Talib Hussain, Ali F. Altebainawi, Afrasim Moin, Riyaz Basha, Kazeem B. Yusuff and Syed Mohd Danish Rizvi and has published in prestigious journals such as Journal of Neurochemistry, Neurobiology of Aging and BMC Public Health.

In The Last Decade

Gehad M. Subaiea

27 papers receiving 504 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gehad M. Subaiea Saudi Arabia 15 137 131 109 92 81 30 509
Fakiha Firdaus India 14 46 0.3× 150 1.1× 118 1.1× 70 0.8× 40 0.5× 20 571
Juan Carlos Gómez-Verján Mexico 15 98 0.7× 227 1.7× 24 0.2× 26 0.3× 26 0.3× 49 631
Cintia B. Dias Australia 15 254 1.9× 145 1.1× 12 0.1× 224 2.4× 45 0.6× 26 735
Ljiljana Gojković‐Bukarica Serbia 14 160 1.2× 165 1.3× 66 0.6× 34 0.4× 22 0.3× 46 618
Sandeep Arora India 11 72 0.5× 111 0.8× 29 0.3× 37 0.4× 30 0.4× 18 440
Rituparna Ghosh India 14 63 0.5× 182 1.4× 103 0.9× 68 0.7× 56 0.7× 30 700
Rajendra Nath India 16 55 0.4× 175 1.3× 49 0.4× 48 0.5× 62 0.8× 58 650
Katherine Gottschall‐Pass Canada 12 44 0.3× 159 1.2× 38 0.3× 143 1.6× 33 0.4× 19 580
Taoguang Huo China 17 128 0.9× 499 3.8× 68 0.6× 46 0.5× 28 0.3× 32 796
Nematollah Ahangar Iran 15 50 0.4× 206 1.6× 39 0.4× 55 0.6× 83 1.0× 53 721

Countries citing papers authored by Gehad M. Subaiea

Since Specialization
Citations

This map shows the geographic impact of Gehad M. Subaiea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gehad M. Subaiea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gehad M. Subaiea more than expected).

Fields of papers citing papers by Gehad M. Subaiea

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gehad M. Subaiea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gehad M. Subaiea. The network helps show where Gehad M. Subaiea may publish in the future.

Co-authorship network of co-authors of Gehad M. Subaiea

This figure shows the co-authorship network connecting the top 25 collaborators of Gehad M. Subaiea. A scholar is included among the top collaborators of Gehad M. Subaiea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gehad M. Subaiea. Gehad M. Subaiea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abdel‐Bar, Hend Mohamed, et al.. (2025). Tailored Intranasal Albumin Caged Selegiline-α Synuclein siRNA Liposome with Improved Efficiency in Parkinson’s Model. Pharmaceutics. 17(2). 243–243. 3 indexed citations
2.
Lila, Amr S. Abu, et al.. (2025). Innovative synergy in wound repair: Valsartan-loaded spanlastics gel coupled with cold atmospheric plasma for improved skin recovery. Journal of Drug Delivery Science and Technology. 115. 107641–107641.
3.
4.
Lila, Amr S. Abu, et al.. (2025). Vesicular drug delivery systems: A breakthrough in wound healing therapies. Colloids and Surfaces B Biointerfaces. 256(Pt 2). 115046–115046.
5.
Alobaida, Ahmed, et al.. (2025). Development of quercetin-loaded liposomal nanocarriers for alleviation of gemcitabine-induced hepatotoxicity: Optimization, in-vitro, and in-vivo evaluation. Journal of Drug Delivery Science and Technology. 105. 106659–106659. 1 indexed citations
6.
7.
Abdel‐Bar, Hend Mohamed, et al.. (2024). Manipulation of Lipid Nanocapsules as an Efficient Intranasal Platform for Brain Deposition of Clozapine as an Antipsychotic Drug. Pharmaceutics. 16(11). 1417–1417. 1 indexed citations
8.
Subaiea, Gehad M., et al.. (2023). Coleus aromaticus Ethanolic Leaves Extract Mediates Inhibition of NF-κB Signaling Pathway in Lung Adenocarcinoma A549 Cells. Processes. 11(5). 1332–1332. 1 indexed citations
9.
Subaiea, Gehad M., Syed Mohd Danish Rizvi, Vikash Kumar Yadav, et al.. (2023). Ganetespib with Methotrexate Acts Synergistically to Impede NF-κB/p65 Signaling in Human Lung Cancer A549 Cells. Pharmaceuticals. 16(2). 230–230. 15 indexed citations
10.
Rizvi, Syed Mohd Danish, et al.. (2022). Molecular docking and dynamic simulation study to explore quercetin as a multi-potent candidate against gliomas. Tropical Journal of Pharmaceutical Research. 20(4). 815–823. 6 indexed citations
11.
Subaiea, Gehad M., Ali F. Altebainawi, & Thamir M. Alshammari. (2019). Energy drinks and population health: consumption pattern and adverse effects among Saudi population. BMC Public Health. 19(1). 52–1539. 35 indexed citations
12.
Hussain, Talib, et al.. (2018). Hepatoprotective evaluation of Trapa natans against drug-induced hepatotoxicity of antitubercular agents in rats. Pharmacognosy Magazine. 14(54). 180–180. 9 indexed citations
13.
Alshammari, Thamir M., Gehad M. Subaiea, Talib Hussain, Afrasim Moin, & Kazeem B. Yusuff. (2017). Parental perceptions, attitudes and acceptance of childhood immunization in Saudi Arabia: A cross sectional study. Vaccine. 36(1). 23–28. 39 indexed citations
14.
Subaiea, Gehad M., et al.. (2017). ACUTE TOXICITY TESTING OF NEWLY DISCOVERED POTENTIAL ANTIHEPATITIS B VIRUS AGENTS OF PLANT ORIGIN. Asian Journal of Pharmaceutical and Clinical Research. 10(11). 210–210. 5 indexed citations
15.
Eid, Assaad A., et al.. (2016). Developmental exposure to lead (Pb) alters the expression of the human tau gene and its products in a transgenic animal model. NeuroToxicology. 55. 154–159. 26 indexed citations
16.
Subaiea, Gehad M., et al.. (2014). Reduction of Amyloid-β Deposition and Attenuation of Memory Deficits by Tolfenamic Acid. Journal of Alzheimer s Disease. 43(2). 425–433. 16 indexed citations
17.
Adwan, Lina, Gehad M. Subaiea, & Nasser H. Zawia. (2014). Tolfenamic acid downregulates BACE1 and protects against lead-induced upregulation of Alzheimer's disease related biomarkers. Neuropharmacology. 79. 596–602. 34 indexed citations
18.
Subaiea, Gehad M., et al.. (2013). Short-term treatment with tolfenamic acid improves cognitive functions in Alzheimer's disease mice. Neurobiology of Aging. 34(10). 2421–2430. 37 indexed citations
19.
Subaiea, Gehad M., et al.. (2011). The Ability of Tolfenamic Acid to Penetrate the Brain: A Model for Testing the Brain Disposition of Candidate Alzheimers Drugs Using Multiple Platforms. Current Alzheimer Research. 8(8). 860–867. 21 indexed citations
20.
Adwan, Lina, Riyaz Basha, Maen Abdelrahim, Gehad M. Subaiea, & Nasser H. Zawia. (2011). Tolfenamic Acid Interrupts the De Novo Synthesis of the β-Amyloid Precursor Protein and Lowers Amyloid Beta Via a Transcriptional Pathway. Current Alzheimer Research. 8(4). 385–392. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fakiha Firdaus Breakdown of academic impact, for papers by Juan Carlos Gómez-Verján Breakdown of academic impact, for papers by Cintia B. Dias Breakdown of academic impact, for papers by Ljiljana Gojković‐Bukarica Breakdown of academic impact, for papers by Sandeep Arora Breakdown of academic impact, for papers by Rituparna Ghosh Breakdown of academic impact, for papers by Rajendra Nath Breakdown of academic impact, for papers by Katherine Gottschall‐Pass Breakdown of academic impact, for papers by Taoguang Huo Breakdown of academic impact, for papers by Nematollah Ahangar
Rankless by CCL
2026